Specifically, MAOB has been proposed as a possible therapeutic target for AD due to its association with aberrant GABA production, but it also has therapeutic relevance for Parkinson’s disease due to its role in dopamine depletion18,46. This evidence concerns the gene MAOB and Parkinson disease.